Tagged with

Lundbeck South Korea What are the origins of Lundbeck in Korea and your involvement in its establishment? I joined Lundbeck just before it was officially established in Korea in April 2002. We started out as a small organization, working through our local partner Whanin. In October that same year we managed to launch…

Korea National Enterprise for Clinical Trials Korea had a late start, but is now one of the global hot spots for clinical trials. How would you sum up and explain this quick evolution? Clinical trials in Korea began in the 1990s, but at that time they were limited to either local studies for domestically developed compounds…

Bayer Indonesia Many multinational companies have chosen to forgo establishing production facilities in Indonesia or have even shuttered their facilities, as did Janssen-Cilag. With the recent 10/10 decree, it seems the environment may become even more hostile to foreign companies. Why has Bayer always had such a strong commitment to the country…

BPOM How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes and upgrades in international standards in the last decade posed strategic choices to our agency. Since then, BPOM chose to…

Ministry of Health & Welfare Italy Following the successful result of the “Piano Sanitario Nazionale” 2005 – 2008, could you introduce to ours readers the key priorities and main health policies to be implemented by 2009 onwards to foster maximum quality and equality in health for all citizens, highlighting those concerning preventive Health? The current government…

Mensa Group Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the API sector? I was studying pharmaceuticals and my first professional position was also in the pharmaceutical industry. The API business…

Parexel International Italy Over more than 25 years, PAREXEL has expanded its global footprint through a combination of organic growth, alliances, and acquisitions. What was the rationale behind entering Italy in 1995 and which opportunities does the local environment provide to the group? The high number of clinical trials conducted in Italy every…

The appointment of Lino Barañao and the establishment of the Ministry of Science and Technology suggest that the government has realised what a large role innovation can play in the Argentine economy. As an institute that has been working in this field for many years now, how do you feel…

generics “The ball is in the hands of the government,” according to Giorgio Foresti, general manager of Ratiopharm. “Once aware of the opportunities created by generics, politicians will have to make hard decisions.” Until now, generics prescriptions were limited by strong links between innovators and doctors, and price alignment trends reducing…

The pharmaceutical industry arose from science – and so did Italy’s knowledge based economy. Building on a reputation for innovation carved in the 15th century, when Leonardo Da Vinci, Michelangelo, Galileo and other icons of the Italian Renaissance helped shape the modern world, the country’s life science industry is now…

The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed in size by Thailand, a country with one quarter the population of Indonesia’s vast archipelago. Some pundits see the country…

Korea   Already an economic powerhouse thriving on export-driven industries such as electronics, automotive and ship-building, South Korea is now looking to boost its potential in the life sciences and to move towards an innovation-based economy. Though it may traditionally be known in the West as ‘The Land of the Morning…